Serotonin and Depression: A Disconnect between the Advertisements and the Scientific Literature
Open Access
- 8 November 2005
- journal article
- review article
- Published by Public Library of Science (PLoS) in PLoS Medicine
- Vol. 2 (12) , e392
- https://doi.org/10.1371/journal.pmed.0020392
Abstract
Many ads for SSRI antidepressants claim that the drugs boost brain serotonin levels. Lacasse and Leo argue there is little scientific evidence to support this claim.Keywords
This publication has 25 references indexed in Scilit:
- Selective serotonin reuptake inhibitors (SSRIs) versus other antidepressants for depressionCochrane Database of Systematic Reviews, 2006
- Is mood chemistry?Nature Reviews Neuroscience, 2005
- Toward a Philosophical Structure for PsychiatryAmerican Journal of Psychiatry, 2005
- Acute treatment of moderate to severe depression with hypericum extract WS 5570 (St John's wort): randomised controlled double blind non-inferiority trial versus paroxetineBMJ, 2005
- Active placebos versus antidepressants for depressionCochrane Database of Systematic Reviews, 2004
- Direct-To-Consumer Marketing of Prescription DrugsCNS Drugs, 2004
- For and against: Direct to consumer advertising is medicalising normal human experience: ForBMJ, 2002
- The Revised Monoamine Theory of Depression: A Modulatory Role for Monoamines, Based on New Findings From Monoamine Depletion Experiments in HumansPharmacopsychiatry, 1996
- Amine Precursors and DepressionArchives of General Psychiatry, 1975
- The Biochemistry of Affective DisordersThe British Journal of Psychiatry, 1967